Focus On: Cancer Signaling January 31, 2022 J.Silvio Gutkind, Ph.D. and Matt Hangauer, Ph.D., UC San Diego
Ketamine metabolism: pharmacology underlying rapid anti-depressant action and leads for anti-depressant drug development June 5, 2019 Todd Gould, M.D., University of Maryland School of Medicine
Target class approach accelerates DUB inhibitory discovery August 27, 2019 Sara Buhrlage, Ph.D. Harvard University
RNA-binding domain disorder modulates the RNA destabilizing activity in the TTP family of proteins October 5, 2016 Special Seminar
Immunopathogenesis of two emerging viruses: ZIKA virus and SFTX virus September 24, 2018 Special Seminar Jae Jung, Ph.D. University of Southern California "Immunopathogenesis of two emerging viruses: ZIKA virus and SFTX virus"
8th Annual C3 Cancer Centers Council Symposium April 22, 2022 Advances in Immuno-Oncology Research Keynote speaker: Jeff Settleman, Ph.D., Chief Scientific Officer, Pfizer